NEW YORK, NY – Peter Davies, PhD, director of the Litwin-Zucker Research Center for The Study of Alzheimer's Disease and Memory Disorders at The Feinstein Institute for Medical Research, served as an expert panelist last Wednesday at the 25th Annual Meeting of the Alzheimer’s Association’s New York City Chapter.
The event, entitled “Crosswords, computers and cognition: What’s going on in your brain?” focused on the role of cognitive stimulation and memory enhancement as a potential treatment or prevention of Alzheimer’s disease and other dementias. Max Gomez, PhD, CBS 2 medical reporter, moderated the event and panelist were Cynthia R. Green, PhD, founder and president of Memory Arts, LLC and assistant clinical professor of psychiatry at Mount Sinai School of Medicine, along with Yaakov Stern, PhD, professor of Clinical Neuropsychology and director of Cognitive Neuroscience Division at Columbia University College of Physicians and Surgeons.
Dr. Davies has been involved in research on Alzheimer’s disease for more than 35 years. One of his current projects is a large-scale whole genome sequencing project, which aims at understanding the genetic basis of why some patients are susceptible to Alzheimer’s disease. There is very little known about the genetic basis for some patients’ susceptibility to Alzheimer’s disease, and knowing more will help evaluate a person’s lifetime risk for developing it. This knowledge will also help scientists develop more effective ways of early detection and identifying new treatments. Partnering with the New York Genome Center (NYGC) and basing a major genome center in Manhasset will offer surrounding communities the opportunity to participate in science and hopefully find answers surrounding Alzheimer’s disease. To learn more or to participate in this initiative or other clinical research, call 877-GO-NSLIJ (466-7545).
About Peter Davies, PhD
Peter Davies, has been involved in research on Alzheimer’s disease for more than 35 years. He is currently Scientific Director of the Litwin-Zucker Center for Research on Alzheimer’s Disease at The Feinstein Institute for Medical Research, North Shore-LIJ. He also holds the Judith and Burton P. Resnick Chair in Alzheimer’s Disease Research at Albert Einstein College of Medicine.
About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information visit www.FeinsteinInstitute.org